The U.S. Food and Drug Administration (FDA) is providing an update to the February 27, 2023 Letter to Health Care Providers about the potential risk of early structural valve deterioration (SVD) with Abbott Trifecta valves, including the Trifecta Valve and Trifecta Valve with Glide Technology (GT)
The Food and Drug Administration has issued a safety alert regarding the potential risk of early structural valve deterioration with Abbott Trifecta valves.
FDA Issues Statement on Abbott Trifecta Valves: Potential Risk of Early Structural Valve Deterioration dicardiology.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dicardiology.com Daily Mail and Mail on Sunday newspapers.
Letters sent by the FDA and Abbott warn about a potential risk of early structural valve deterioration with the Abbott Trifecta valve and Trifecta valve with glide technology.
/PRNewswire/ Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: Today, the FDA is withdrawing.